Get started
Author

Evangeline R. Jackson

Observed names: Evangeline Jackson, Evangeline R Jackson, Jackson, Evangeline, Jackson, Evangeline R, Jackson, Evangeline R.
ORCID: 0000-0002-2245-9213
Observed ORCID: 0000-0002-2245-9213
OpenAlex ID: A5000958028
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
2023 · Evangeline R. Jackson, Ryan J. Duchatel, et al. · Cancer Research · 91
PDF
Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies
2021 · Izac J. Findlay, Geoffry N. De Iuliis, et al. · Oncogene · 83
PDF
B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric Cancers
2022 · Tabitha McLachlan, William C. Matthews, et al. · Molecular Cancer Research · 62
Signal Transduction in Diffuse Intrinsic Pontine Glioma
2019 · Ryan J. Duchatel, Evangeline R. Jackson, et al. · PROTEOMICS · 62
PDF
Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma
2021 · Ryan J Duchatel, Abdul Mannan, et al. · Neuro-Oncology Advances · 50
PDF
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma
2024 · Ryan J. Duchatel, Evangeline R. Jackson, et al. · Journal of Clinical Investigation · 45
A review of current therapeutics targeting the mitochondrial protease ClpP in diffuse midline glioma, H3 K27-altered
2023 · Evangeline R Jackson, Mika L Persson, et al. · Neuro-Oncology · 38
PDF
Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma
2024 · Lauren M. Arms, Ryan J. Duchatel, et al. · Journal of Controlled Release · 28
Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies
2023 · Zacary P. Germon, Jonathan R. Sillar, et al. · Science Signaling · 25
Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma
2023 · Alyssa Noll, Carrie Myers, et al. · Neoplasia · 16
Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection
2022 · Dilana E. Staudt, Heather C. Murray, et al. · Clinical Proteomics · 7
PDF
Beyond base camp: PI3K/mTOR inhibition for the treatment of pediatric high-grade gliomas
2025 · Ryan J Duchatel, Clara Savary, et al. · Neuro-Oncology · 6
The redox paradox in HGGs: ROS as drivers and destroyers
2026 · Pooja Kumari, Zacary P. Germon, et al. · Trends in cancer · 5
Dipg-03. Targeting Pi3k Using the Blood Brain Barrier Penetrable Inhibitor, Gdc-0084, for the Treatment of Diffuse Intrinsic Pontine Glioma (dipg)
2019 · Ryan Duchatel, Evangeline Jackson, et al. · Neuro-Oncology · 5
PDF
Blockade of redox second messengers inhibits JAK/STAT and MEK/ERK signaling sensitizing FLT3-mutant acute myeloid leukemia to targeted therapies
2022 · Zacary P. Germon, Jonathan R. Sillar, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 3
PDF
Dipg-29. Phosphatidylinositol-4,5-bisphosphate 3-kinase (pi3k) Inhibition Drives Protein Kinase C Activation (pkc) in Diffuse Intrinsic Pontine Glioma (dipg)
2020 · Ryan J Duchatel, Abdul Mannan, et al. · Neuro-Oncology · 2
Cutting through complexity: Spatial multi-omics in the fight against DIPG/DMG
2026 · Tuan Vo, Clara Savary, et al. · Neuro-Oncology Pediatrics · 1
Beyond Base Camp: Promise and Pitfalls of PI3K/mTOR Inhibition in Pediatric High- Grade Gliomas
2025 · Ryan J. Duchatel, Clara Savary, et al. · Research Square · 1
PDF
Dipg-36. Drd2 Antagonism Rescues Immune-tumor Surveillance, Warming the Tumor Immune Microenvironment of Diffuse Midline Glioma Models
2024 · Mika L Persson, Evangeline R Jackson, et al. · Neuro-Oncology · 1
PDF
Phospho heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection
2022 · Dilana E. Staudt, Heather C. Murray, et al. · Research Square · 1
PDF
Dipg-32. Akt Signaling Drives Resistance to Onc201 in Diffuse Intrinsic Pontine Glioma (dipg)
2020 · Evangeline R Jackson, Ryan J Duchatel, et al. · Neuro-Oncology · 1
PDF
Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
2025 · Evangeline R. Jackson, Ryan J. Duchatel, et al.
Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
2025 · Evangeline R. Jackson, Ryan J. Duchatel, et al.
Epco-11. Enhancing Genome Analysis With Whole Proteome Profiling for Improved Therapeutic Decision Making in Diffuse Midline Glioma
2025 · Izac Findlay, Dilana Staudt, et al. · Neuro-Oncology
PDF
EXTH-83. Exploiting Cell-of-Origin Vulnerabilities to Guide Multimodal Strategies in Diffuse Midline Glioma
2025 · Matthew Dun, Evangeline Jackson, et al. · Neuro-Oncology
PDF
Works count: 67
Citation count: 533
H-index: 10
I10-index: 10
Year
Topic
Type